TECHWIRE 30
(CIX: WRAL30)  1,123.60  down arrow-1.21  (-0.11 %)  Updated: 08:10 PM EDT, Aug 28 2015
(NQ: Apple)  113.29  up arrow+0.37  (0.33 %)  Updated: 08:10 PM EDT, Aug 28 2015
(NY: QUINTILES)  75.24  up arrow+1.04  (1.4 %)  Updated: 06:40 PM EDT, Aug 28 2015
(OP: BASF SE)  80.48  down arrow-0.5  (-0.62 %)  Updated: 05:20 PM EDT, Aug 28 2015
(NQ: BioCryst)  11.42  up arrow+0.21  (1.87 %)  Updated: 08:10 PM EDT, Aug 28 2015
(NQ: BioDelivery)  6.87  up arrow+0.23  (3.46 %)  Updated: 08:10 PM EDT, Aug 28 2015
(NQ: CEMP)  35.80  up arrow+1.4  (4.07 %)  Updated: 08:10 PM EDT, Aug 28 2015
(NQ: Cisco)  26.00  down arrow-0.17  (-0.65 %)  Updated: 08:10 PM EDT, Aug 28 2015
(NQ: Cree)  26.99  up arrow+0.06  (0.22 %)  Updated: 08:10 PM EDT, Aug 28 2015
(NQ: DARA)  0.86  up arrow+0.01  (1.32 %)  Updated: 08:10 PM EDT, Aug 28 2015
(NY: EMC)  24.96  down arrow-0.06  (-0.24 %)  Updated: 06:40 PM EDT, Aug 28 2015
(NQ: Extreme Networks)  2.80  up arrow+0.05  (1.82 %)  Updated: 08:10 PM EDT, Aug 28 2015
(NQ: Facebook)  91.01  up arrow+1.28  (1.43 %)  Updated: 08:10 PM EDT, Aug 28 2015
(NY: GLAXOSMITHKLINE)  41.25  up arrow+0.04  (0.1 %)  Updated: 06:40 PM EDT, Aug 28 2015
(NQ: Google)  630.38  down arrow-7.23  (-1.13 %)  Updated: 08:10 PM EDT, Aug 28 2015
(NY: IBM)  147.98  down arrow-0.56  (-0.38 %)  Updated: 06:40 PM EDT, Aug 28 2015
(NY: LH)  119.61  down arrow-0.21  (-0.18 %)  Updated: 06:40 PM EDT, Aug 28 2015
(OP: Lenovo Group)  17.21  up arrow+0.65  (3.93 %)  Updated: 05:20 PM EDT, Aug 28 2015
(NY: MRK)  55.37  up arrow+0.42  (0.76 %)  Updated: 06:40 PM EDT, Aug 28 2015
(NQ: Microsoft)  43.93  up arrow+0.03  (0.07 %)  Updated: 08:10 PM EDT, Aug 28 2015
(NQ: NetApp)  31.62  up arrow+0.23  (0.73 %)  Updated: 08:10 PM EDT, Aug 28 2015
(NY: NOVARTIS AG)  98.35  down arrow-0.29  (-0.29 %)  Updated: 06:40 PM EDT, Aug 28 2015
(OP: Novozymes A/S)  43.69  down arrow-0.3  (-0.68 %)  Updated: 05:20 PM EDT, Aug 28 2015
(NY: Pfizer)  32.66  down arrow-0.6  (-1.8 %)  Updated: 06:40 PM EDT, Aug 28 2015
(NQ: Pozen)  8.85  up arrow+0.02  (0.23 %)  Updated: 08:10 PM EDT, Aug 28 2015
(NY: Red Hat)  73.86  down arrow-0.34  (-0.46 %)  Updated: 06:40 PM EDT, Aug 28 2015
(NQ: BBRY)  7.37  up arrow+0.18  (2.5 %)  Updated: 08:10 PM EDT, Aug 28 2015
(NQ: Salix)  172.81    (0 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: SQI)  11.05  up arrow+0.07  (0.64 %)  Updated: 08:10 PM EDT, Aug 28 2015

Posts tagged “Biotech & Life Science”

10:34 a.m. yesterday

Judge orders billionaire Murdock, exec to pay $148M in Dole buyout fight

David Murdock   Billionaire David Murdock, the founder of the North Carolina Research Campus in Kannapolis, and an executive at Dole Food have been ordered to pay $148 million in a dispute over Murdock's buyout of that company in 2013. The judge says Dole directors and shareholders were mislead in the deal.

10:01 a.m. yesterday

Behind $1.85B Novo Nordisk deal: It takes a quiet team effort

When a chorus of cheers accompanies announcements like the $1.85 billion Novo Nordisk expansion in Clayton, the echo is a reminder: it only happens because a lot of behind-the-scenes work quietly makes it possible.

Novo Nordisk Clayton plant Novo Nordisk Clayton plant

7:25 a.m. yesterday

Pharmaceutical firm adding 110 jobs in $65M Greenville expansion

New jobs     Mayne Pharma, which already operates a big production plant in Greenville, is going to add as many as 110 jobs as part of a $65 million expansion plan. Jobs include scientists, manufacturing and other positions. It's the second big life science expansion announced in N.C. this week.

Updated 6:31 a.m. yesterday

FDA lays out proposal for naming lower-cost biotech - or 'biosimilar' - drugs

FDA   The Food and Drug Administration has released its proposal for naming lower-cost biotech drugs, a critical step in creating a market for the new class of medicines called "biosimilars." Plus: Read the full statement from the FDA.

5:40 a.m. Thursday

Facebook testing own Siri; Windows 10 on 75M devices; Ashley Madison lawsuits; booze in space; diabetes drug cuts complications

Bulldog In today's Bulldog wrapup of technology and life science news: Facebook is testing its own digital assistant; Microsoft says Windows 10 now on 75 million machines; Ashley Madison faces lawsuits after hack; booze arrives at the international space station; and for the first time a diabetes drug is said to be cutting complications associated with the disease.

Updated 8:49 p.m. Wednesday

Clayton celebrates 'huge' Novo Nordisk expansion

Clayton and Johnston County celebrated a big win in the competition for high-paying jobs Wednesday when Novo Nordisk announced plans to expand its plant there by almost 700 employees.

Updated 7:12 p.m. Wednesday

Novo Nordisk adding nearly 700 jobs in Johnston County expansion

Novo Nordisk in Clayton Novo Nordisk is expanding its drug-making presence in Johnston County with a facility that will add 691 jobs. The average wage will be $68,420. Novo Nordisk plans to invest $1.2 billion in the new facility. The state commits more than $18 million in incentives to the project.

12:12 p.m. Wednesday

Monsanto drops its $47B bid to acquire Syngenta

Syngenta's new lab in RTP Agricultural business giant Monsanto is abandoning its takeover bid for competitor Syngenta AG after the Swiss chemical producer rejected its latest offer of roughly $47 billion.

7:29 a.m. Wednesday

Look for big life science jobs announcement today in Johnston County

New jobs     State and county executives are expected to announcement a big economic development project that will create "several hundred full-time" jobs in Johnston County. And WRAL TechWire is told that the deal is with a life science company.

Updated 8:24 a.m. Tuesday

Premium Lock One-on-one with Christy Shaffer: What Hatteras' new $90M fund means, impact of her promotion; and why Triangle life science sector is so hot

In a Q&A, Triangle veteran life science executive turned venture capitalist Christy Shaffer talks with WRAL TechWire about the new $90 million venture fund raised by Hatteras Ventures, what her promotion says about female VCs, and why the Triangle life science sector is so hot.

Christy Shaffer Christy Shaffer

6:55 a.m. Tuesday

Pfizer-Hospira deal nears close; Lenovo phones No. 1 in India; Cortona goes Android; Facebook guilty 'spam' plea; driverless crash truck

Bulldog In today's Bulldog wrapup of technology and life science news: The Pfizer-Hospira deal nears a close; Lenovo is No. 1 in 4g smartphones across India; Microsoft offers beta on Cortana for Android; a guilty please in a Facebook spam case; and a driverless crash truck debuts.

5:35 a.m. Monday

Triangle tech calendar: Raleigh Startup Crawl, Innovate Raleigh, Jim Whitehurst, WTW's Internet of Things

Social networking August wraps with a bang - Jim Whitehurst of Red Hat's leadership talk - then September brings a host of events: Innovate Raleigh, the Startup Crawl, CED's Tech Venture, WRAL TechWire's Internet of Things event - and much more. Check out the highlights.

5:30 a.m. Monday

WTW news in review: Week of Aug. 16 (Part 1)

Week in review Here's a look back at technology, life science and other related news as reported in WRAL TechWire for the week of Aug. 16, part one.

5:28 a.m. Monday

WTW news in review: Week of Aug. 16 (Part 2)

Week in Review Here's a look back at technology, life science and other related news as reported in WRAL TechWire the week of Aug. 16, part two.

5:25 a.m. Monday

We want your news - and your opinions: Share them with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

Updated August 21

Premium Lock Sprout, AgBiome deals reflect new muscle in life science investing

Biotech, agscience, life science Want proof that life science startups and emerging firms are back as targets for investment capital? Raleigh's Sprout Pharmaceuticals is being sold for $1 billion and RTP startup AgBiome has raised an impressive $34.5 million. But these aren't the only indicators that VCs and private equity see biotech and pharmaceuticals as good bets once again.

Updated August 21

Inside Sprout's $1B payday: It didn't likely grow overnight; meanwhile, buyer takes big hit

So Raleigh's Sprout Pharmaceuticals sells itself for $1 billion plus royalties in the future within 48 hours of winning approval for its "little pink pill" - is this a Jackie and the beanstalk story with success sprouting overnight? By the way, initial reaction on Wall Street to Valeant's buy is very negative.

Execs at Sprout are "on a mission" Execs at Sprout are "on a mission"

Updated August 21

Growing fast: RTP startup AgBiome to add staff, sales team, move into new facilities

Only two years after it raised $17.5 million in venture capital, AgBiome of Research Triangle Park announced today it has raised an additional $34.5 million to fund research and the projected launch of its first product, a natural fungicide for crops and turf grasses. Yes, the RTP startup is growing fast.

AgBiome's future home in RTP AgBiome's future home in RTP

August 21

Novartis buying GSK multiple sclerosis drug for $1B plus royalties

GSK's HQ in London            GlaxoSmithKline has struck another major deal with Novartis. This time the drug giants are teaming up for a deal worth more than $1 billion plus royalties to GSK for an experimental multiple sclerosis drug. The deal will help GSK focus on other priorities, a top executive says.

Updated August 20

Gates Foundation invests in RTP's AgBiome to help 'poor farmers'

Bill Gates The Bill & Melinda Gates Foundations is backing RTP-based Startup AgBiome with hard dollars, hoping the company's crop science technology will lead to better harvests - especially for "poor farmers."

Techwire Inside Partners
The Skinny: A Blog by Rick Smith